AARS2 and cardiomyopathy: We identified mutations in the gene for mitochondrial alanyl-tRNA synthetase (AARS2) in a phenotype that differs from the other reported mtARS defects, being clinically a fatal early onset cardiomyopathy (Gotz et al., 2011).